Table 1.

Demographical and clinical findings of treatment groups (mean ± SD)

Parameter	Metranidazol Group (n=29)	Albendazol Group (n=28)	P
Female /Male	18/11	15/13	#
Age (yr)	38 ± 14	41 ± 12	#
Hemoglobin	13.2 ± 1.5	12.7 ± 1.5	#
Leukocyte count	7 996 ± 2 668	8 225 ± 3 016	#
Faecal examination positive	0	0	NA
for cysts or trophozoits on d 7
Faecal examination positive for	0	1	NA
cysts or trophozoits on d 15
Metal taste	9	0	NA
Anorexia +/-	18	2	0.0001
Abdominal pain	3	1	#
After starting treatment	83 ± 39	80 ± 28	#
healing of symptoms (h)
Advers effects other than anorexia	8	6	#
Non-compliance to treatment	7	5	#

#: P > 0.05, NA: Not applicable.